 |
인쇄하기
취소
|
Top 10 import medicines in 2008 outlined
The nation imported Prevenar, a heptavalent vaccine, amounting to $44.26 million in 2008, according to data released by the Korea Pharmaceutical Manufacturers Association.
By import performance record, Glivec came in second with $42.45 million, followed by GlaxoSmithKline’s Hepsera with $22.73 million and Pfizer’s Norvasc with $22.46 million.
Among the top 10 items included Baraclude ($19...
By import performance record, Glivec came in second with $42.45 million, followed by GlaxoSmithKline’s Hepsera with $22.73 million and Pfizer’s Norvasc with $22.46 million.
Among the top 10 items included Baraclude ($19...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.